Stockreport

Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Nee...

Tevogen Bio Holdings Inc.  (TVGN) 
PDF WARREN, N.J.--(BUSINESS WIRE)--Tevogen Bio Holdings Inc. ('Tevogen Bio') (Nasdaq: TVGN)Tevogen’s ExacTcell platform was developed to harness the killing ability of n [Read more]